Hyperbilirubinemia Clinical Trial
Official title:
Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?
Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted)
phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low
birth weight newborns in a pilot randomized controlled trial.
Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous
phototherapy in extremely low birth weight (ELBW) infants without the risks that have been
associated with continuous phototherapy.
Phototherapy (PT) is widely used and assumed to be safe as well as effective in reducing
total bilirubin (TB) levels. Our recent NICHD Network Trial showed that aggressive use of
phototherapy reduces neurodevelopmental impairment (NDI), but may increase deaths among ELBW
infants. Among ventilator treated infants <750 g birth weight (BW) (n =696), conservative
Bayesian analyses (using a neutral prior probability) identified a 99% (posterior)
probability that aggressive phototherapy reduced profound NDI but a 99% probability that it
increased deaths relative to conservative phototherapy. The possibility that PT increases
deaths among high risk infants is also suggested by the Collaborative Phototherapy trial
(performed in the 1970s), the only large RCT in which LBW infants were randomly assigned to
receive PT or no PT. The relative risk for death among those randomized to PT relative to
those randomized to no PT was 1.32 (0.9-1.82) among all LBW infants and 1.49 (0.93-2.40)
among ELBW infants. These findings are consistent with a major increase in mortality but
have been ignored because the p was >0.05, an error often made in ignoring important
potential treatment hazards when power is limited.
Multiple studies, most performed decades ago in larger infants, found that short on/off
cycles of PT (e.g. 15 min on/60 min off, 1 h on/3 h off, or 1 h on/1 h off ) are as
effective as uninterrupted PT to reduce TSB. (Cycles with >6 h off PT do not appear to be as
effective as uninterrupted PT). The clinical use of uninterrupted rather than cycled PT
appears to be based largely on the assumption that PT is safe for all infants.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00360204 -
Improving Health Outcomes for New Mothers and Babies
|
Phase 3 | |
Completed |
NCT00383318 -
Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
|
N/A | |
Completed |
NCT00115544 -
Safety and Pharmacology of Stanate
|
Phase 2 | |
Completed |
NCT01622699 -
Implementation of a Transcutaneous Bilirubinometer
|
N/A | |
Terminated |
NCT00741117 -
Conjugated Hyperbilirubinemia and Pulse Oximetry
|
N/A | |
Completed |
NCT00288600 -
Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
|
Phase 4 | |
Completed |
NCT02774434 -
Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age
|
N/A | |
Completed |
NCT01550627 -
Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy
|
Phase 0 | |
Completed |
NCT00653874 -
Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates
|
Phase 3 | |
Recruiting |
NCT03564678 -
Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia
|
Phase 2 | |
Recruiting |
NCT04897113 -
Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old
|
N/A | |
Completed |
NCT00635375 -
Comparative Study of Phototherapy for Hyperbilirubinemia
|
N/A | |
Completed |
NCT03195998 -
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
|
||
Terminated |
NCT02685189 -
Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)
|
||
Completed |
NCT02446951 -
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
|
||
Terminated |
NCT01136577 -
Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn
|
N/A | |
Completed |
NCT04271098 -
The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries
|
||
Completed |
NCT02691156 -
Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants
|
||
Completed |
NCT00004381 -
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
|
Phase 2 | |
Completed |
NCT00004382 -
Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
|
Phase 2 |